Erratum: E-Cigarettes May Support Smokers with High Smoking-Related Risk Awareness to Stop Smoking in the Short Run: Preliminary Results by Randomized Controlled Trial (Nicotine & Tobacco Research (2018) DOI: 10.1093/ntr/nty047);E-cigarettes may support smokers with high smoking-related risk awareness to stop smoking in the short run: Preliminary results by randomized controlled trial

Nicotine and Tobacco Research

Volumn 21, Issue 1, 2019, Pages 119-126

  Masiero, Marianna ^a,b   Lucchiari, Claudio ^a   Mazzocco, Ketti ^a,b   Veronesi, Giulia ^c   Maisonneuve, Patrick ^b   Jemos, Costantino ^b   Salè, Emanuela Omodeo ^b   Spina, Stefania ^c   Bertolotti, Raffaella ^b   Pravettoni, Gabriella ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DYSPNEA; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PATIENT COUNSELING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAFETY; SMOKING CESSATION; ATTITUDE TO HEALTH; COUNSELING; EARLY CANCER DIAGNOSIS; ELECTRONIC CIGARETTE; EPIDEMIOLOGY; HEALTH BEHAVIOR; LUNG TUMOR; PROCEDURES; PSYCHOLOGY; SMOKING; SMOKING PREVENTION;

COUNSELING; DOUBLE-BLIND METHOD; EARLY DETECTION OF CANCER; ELECTRONIC NICOTINE DELIVERY SYSTEMS; FEMALE; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NICOTINE; SMOKERS; SMOKING CESSATION; SMOKING PREVENTION; TOBACCO SMOKING;

EID: 85058923434     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/nty175     Document Type: Erratum

References (46)

1. Doll R, Gray R, Hafner B, Peto R. Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J. 1980;280(6219):967-971.
2. Berg CJ, Thomas AN, Mertens AC, et al. Correlates of continued smoking versus cessation among survivors of smoking-related cancers. Psychooncology. 2013;22(4):799-806.
3. Masiero M, Riva S, Fioretti C, Pravettoni G. Pediatric blood cancer survivors and tobacco use across adolescence and emerging adulthood: A narrative review. Front Psychol. 2016;7:392.
4. Lucchiari C, Masiero M, Botturi A, Pravettoni G. Helping patients to reduce tobacco consumption in oncology: A narrative review. Springerplus. 2016;5(1):1136.
5. Salloum RG, Getz KR, Tan ASL, et al. Use of electronic cigarettes among cancer survivors in the U.S. Am J Prev Med. 2016;51(5):762-766.
6. Perret JL, Bonevski B, McDonald CF, Abramson MJ. Smoking cessation strategies for patients with asthma: Improving patient outcomes. J Asthma Allergy. 2016;9:117-128.
7. Stead LF, Perera R, Bullen C, Mant D, Hartmann-Boyce J, Cahill K, Lancaster T. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012;11(11).
8. Ferguson SG, Gitchell JG, Shiffman S, Sembower MA, Rohay JM, Allen J. Providing accurate safety information may increase a smoker's willingness to use nicotine replacement therapy as part of a quit attempt. Addict Behav. 2011;36(7):713-716.
9. Balmford J, Borland R, Hammond D, Cummings KM. Adherence to and reasons for premature discontinuation from stop-smoking medications: Data from the ITC Four-Country Survey. Nicot Tob Res. 2011;13(2):94-102.
10. Barbeau AM, Burda J, Siegel M. Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: A qualitative approach. Addict Sci Clin Pract. 2013;8(1):5.
11. Harrell PT, Marquinez NS, Correa JB, et al. Expectancies for cigarettes, e-cigarettes, and nicotine replacement therapies among e-cigarette users (aka vapers). Nicot Tob Res. 2015;17(2):193-200.
12. Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: Randomised cross-over trial. Tob Control. 2010;19(2):98-103.
13. Regan AK, Promoff G, Dube SR, Arrazola R. Electronic nicotine delivery systems: Adult use and awareness of the 'e-cigarette' in the USA. Tob Control. 2013;22(1):19-23.
14. Healton GC. Tobacco control: How are we doing? Am J Public Health. 2016;106(7):1164-1166.
15. Zhuang YL, Cummins SE, Sun JY, Zhu SH. Long-term e-cigarette use and smoking cessation: A longitudinal study with US population. Tob Control. 2016;25(Suppl 1):i90-i95.
16. Bullen C, Howe C, Laugesen M, et al. Electronic cigarettes for smoking cessation: A randomised controlled trial. Lancet. 2013;382(9905):1629-1637.
17. Caponnetto P, Campagna D, Cibella F, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: A prospective 12-month randomized control design study. PLoS One. 2013;8(6):e66317.
18. Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C. Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: A prospective 6-month pilot study. BMC Public Health. 2011;11(1):786.
19. Etter JF, Bullen C. A longitudinal study of electronic cigarette users. Addict Behav. 2014;39(2):491-494.
20. Grana RA, Popova L, Ling PM. A longitudinal analysis of electronic cigarette use and smoking cessation. JAMA Intern Med. 2014;174(5):812-813.
21. McRobbie H., Bullen CR., Hajek P., Hartmann-Boyce J. Electronic cigarettes for smoking cessation and reduction. Cochrane Review. 2014;12:1-8.
22. Knight-West O, Bullen C. E-cigarettes for the management of nicotine addiction. Subst Abuse Rehabil. 2016;7:111-118.
23. Benowitz NL, Goniewicz ML. The regulatory challenge of electronic cigarettes. JAMA. 2013;310(7):685-686.
24. Sussan TE, Gajghate S, Thimmulappa RK, et al. Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model. PLoS One. 2015;10(2):e0116861.
25. Gallus S, Lugo A, Pacifici R, Pichini S, Colombo P, Garattini S, La Vecchia C. E-cigarette awareness, use, and harm perception in Italy: A national representative survey. Nicot Tob Res. 2014;16(12):1-8.
26. Borondy Kitts AK, McKee AB, Regis SM, Wald C, Flacke S, McKee BJ. Smoking cessation results in a clinical lung cancer screening program. J Thorac Dis. 2016;8(Suppl 6):S481-S487.
27. Reilly M, Delanty N, Lawson JA, FitzGerald GA. Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation. 1996;94(1):19-25.
28. Bergström J, Eliasson S, Dock J. A 10-year prospective study of tobacco smoking and periodontal health. J. Periodontol. 2000;71(8):1338-1347.
29. Cox LS, Wick JA, Nazir N. et al. Predictors of early versus late smoking abstinence within a 24-month Disease Management Program. Nicot Tob Res. 2011;13(3):215-220.
30. Maisonneuve P, Bagnardi V, Bellomi M, et al. Lung cancer risk prediction to select smokers for screening CT-a model based on the Italian COSMOS trial. Cancer Prevention Research. 2011;4(11):1778-1789.
31. Lucchiari C, Masiero M, Veronesi G, et al. Benefits of E-Cigarettes among heavy smokers undergoing a lung cancer screening program: Randomized controlled trial protocol. Eysenbach G, ed. JMIR Res Protoc. 2016;5(1):e21.
32. Birring S, Prudon B, Carr A, Singh S, Morgan M, Pavord I. Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax. 2003;58(4):339-343.
33. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The fagerström test for nicotine dependence: A revision of the fagerström tolerance questionnaire. Br J Addict. 1991;86(9):1119-1127.
34. Marino L. "La disassuefazione dal fumo: l'ambulatorio." L'epidemia di fumo in Italia. Pisa: EDI-AIPO Scientifica. 2000.
35. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-370.
36. Mykletun A, Overland S, Aarø LE, Liabø HM, Stewart R. Smoking in relation to anxiety and depression: Evidence from a large population survey: The HUNT study. Eur Psychiatry. 2008;23(2):77-84.
37. Sawilowsky SS, Blair RC. A more realistic look at the robustness and Type II error properties of the t test to departures from population normality. Psychol Bull. 1992;111(2):352.
38. Tammemägi MC, Berg CD, Riley TL, Cunningham CR, Taylor KL. Impact of lung cancer screening results on smoking cessation. J Natl Cancer Inst. 2014;106(6):dju084.
39. Borland R. Electronic cigarettes as a method of tobacco control. BMJ. 2011;343:d6269.
40. Wagener TL, Floyd EL, Stepanov I, et al. Have combustible cigarettes met their match? The nicotine delivery profiles and harmful constituent exposures of second-generation and third-generation electronic cigarette users. Tobacco control. Tob Control. 2016: 1-6.
41. Riva S, Camerini AL, Allam A, Schulz PJ. Interactive sections of an Internet-based intervention increase empowerment of chronic back pain patients: Randomized controlled trial. J Med Internet Res. 2014;16(8):e180.
42. Schulz PJ, Hartung U, Riva S. Causes, coping, and culture: A comparative survey study on representation of back pain in three Swiss language regions. PLoS One. 2013;8(11):e78029.
43. Kondylakis H, Koumakis L, Genitsaridi E, et al. IEmS: A collaborative environment for patient empowerment. In Bioinformatics & Bioengineering (BIBE), IEEE 12th International Conference on. 2012: 535-540. doi:10.1109/bibe.2012.6399770
44. Lucchiari C, Pravettoni G. Cognitive balanced model: A conceptual scheme of diagnostic decision making. J Eval Clin Pract. 2012;18(1):82-88.
45. Gorini A, Mazzocco K, Gandini S, Munzone E, McVie G, Pravettoni G. Development and psychometric testing of a breast cancer patient-profiling questionnaire. Breast Cancer. 2015;7:133.
46. Kondylakis H, Kazantzaki E, Koumakis L, et al. Development of interactive empowerment services in support of personalised medicine. Ecancermedicalscience. 2014;8:1-14.